GlassScriptPhysician profile
Lucas Samuel Tebbe
NPI 1417519257
$4,502.12
in general payments reported to CMS, 2019-2025
27 companies · $164 in 2025
The $164 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $593 · 2020: $775 · 2021: $1,388 · 2022: $1,297 · 2023: $151 · 2024: $134 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $449.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $448.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $1,486.33 | 2019-2022 | |
| Stryker Corporation | $547.11 | 2020-2022 | |
| Organogenesis INC. | $340.32 | 2019-2023 | Puraply |
| Kci USA, INC. | $301.29 | 2020-2021 | |
| Zimmer Biomet Holdings, INC. | $270.59 | 2019-2021 | |
| Tenex Health INC. | $249.70 | 2020 | |
| Medline Industries LP | $216.50 | 2021-2022 | |
| Bioventus LLC | $185.66 | 2022 | |
| Integra Lifesciences Corporation | $181.91 | 2020-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Bone Support INC. | $102.16 | 2019 | |
| In2bones USA, LLC | $68.21 | 2021 | |
| Kerecis Limited | $67.98 | 2022-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Smith+Nephew, INC. | $64.98 | 2023-2025 | Collagenase Santyl |
| Globus Medical, INC. | $61.08 | 2025 | Senza |
| Celularity INC. | $59.00 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $47.42 | 2021-2025 | Restrata Wound Matrix |
| Djo, LLC | $33.93 | 2024 | Cmf |
| Treace Medical Concepts, INC. | $32.08 | 2022-2025 | |
| Convatec INC. | $29.75 | 2023 | |
| Titan Surgical Group, LLC | $28.20 | 2024 | |
| Depuy Synthes Sales INC. | $24.18 | 2024 | Motoband, Minibunion, Motoband Cp |
| Biotissue Holdings INC. | $22.24 | 2023 | |
| Amgen INC. | $20.26 | 2025 | Krystexxa |
| Horizon Therapeutics Plc | $18.60 | 2023 | Krystexxa |
| Mimedx Group, INC. | $18.15 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $13.45 | 2023 | Seglentis |
| 3m Company | $11.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lucas Tebbe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.